Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Actusnews Wire-Archiv vom 11.12.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
11.12.23OL GROUPE: Conclusion of an agreement between OL Groupe, Mr. Jean-Michel Aulas and Holnest368Disclosure relating to the conclusion of related party agreements pursuant to articles L. 22-10-13 and R. 22-10-17 of the French Commercial Code Lyon, 11 December 2023 - 7.00 pm On 11 December...
► Artikel lesen
11.12.23VENTE-UNIQUE.COM: Disclosure of trading in own shares323Press release 11 December 2023. Vente-unique.com, an expert in online sales of furniture and home furnishings in Europe, declares that it has bought back its own shares in accordance with Article...
► Artikel lesen
11.12.23PRISMAFLEX INTERNATIONAL: 2023-2024 half-year results: Significant improvement in results - Return to profitability - Reduction of net debt3962023-2024 six-month period analysis Total sales down on the high basis of comparison recorded in S1 2022-2023 but very close to levels recorded in S2 2022-2023. Current EBITDA significantly...
► Artikel lesen
11.12.23ROCHE BOBOIS: 2024 FINANCIAL CALENDAR360Paris, 11 December 2023 ROCHE BOBOIS SA (ISIN: FR0013344173 - Ticker symbol: RBO), high-end furniture global market leader and the name behind French Art de Vivre, announces its provisional calendar...
► Artikel lesen
11.12.23ECONOCOM: Treasury shares321Press release REGULATED INFORMATION 11 December 2023 Treasury shares As part of the treasury shares buybacks approved by the general meeting of shareholders on 30 November 2021, Econocom Group...
► Artikel lesen
11.12.23PHARNEXT: Pharnext reports topline results from the pivotal Phase III clinical trial (PREMIER trial) of PXT3003 in Charcot-Marie-Tooth disease type 1A521PARIS, France, December 11, 2023, 08:30 am CET - Pharnext SA (FR001400JXB0 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for...
► Artikel lesen
11.12.23EXAIL TECHNOLOGIES (ex GROUPE GORGE): New commercial success in Land Defense for a demining application342Press release Paris, 11 December 2023 Exail Technologies announces that it has been won a new contract representing a few millions of euros for a land mine-clearance application for the French...
► Artikel lesen